Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer

KOJI OBA, MICHIYA KOBAYASHI, TAKANORI MATSUI, YASUHIRO KODERA and JUNICHI SAKAMOTO
Anticancer Research July 2009, 29 (7) 2739-2745;
KOJI OBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: oba{at}pbh.med.kyoto-u.ac.jp
MICHIYA KOBAYASHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKANORI MATSUI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUHIRO KODERA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNICHI SAKAMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Flow diagram through the stages of the meta-analysis. *One reference (25) included 2 trials. RCT, Randomized controlled trial; IPD, individual patient data. pts, patients.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Kaplan-Meier curve of overall survival. MST, median survival time.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Forest plot of hazard ratios and corresponding 95% confidence intervals. LNT, Lentinan; MMC, mitomycin C; T, tegafur; 5-FU, 5-fluorinated pyrimidine; UFT, tegafur-uracil.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Subgroup analysis based on 6 baseline characteristics. LNT, Lentinan; MMC, mitomycin C; T, tegafur; 5-FU, 5-fluorinated pyrimidine; Pmeta, peritoneal metastasis; Hmeta, hepatic metastasis; Nmeta, lymph-node metastasis.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 7
July 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
17 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer
KOJI OBA, MICHIYA KOBAYASHI, TAKANORI MATSUI, YASUHIRO KODERA, JUNICHI SAKAMOTO
Anticancer Research Jul 2009, 29 (7) 2739-2745;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Individual Patient Based Meta-analysis of Lentinan for Unresectable/Recurrent Gastric Cancer
KOJI OBA, MICHIYA KOBAYASHI, TAKANORI MATSUI, YASUHIRO KODERA, JUNICHI SAKAMOTO
Anticancer Research Jul 2009, 29 (7) 2739-2745;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • How do tumours outside the gastrointestinal tract respond to dietary fibre supplementation?
  • MPSSS impairs the immunosuppressive function of cancer-associated fibroblasts via the TLR4-NF-{kappa}B pathway
  • Accelerated Wound Healing on the Skin Using a Film Dressing with {beta}-Glucan Paramylon
  • The Effect of Lentinan Combination Therapy for Unresectable Advanced Gastric Cancer
  • Google Scholar

More in this TOC Section

  • Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study
  • Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab
  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire